Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Inclisiran
Related studies linked through entity extraction aliases.
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
- Status
- RECRUITING
- Phase
- PHASE3
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
- Status
- RECRUITING
- Phase
- N/A
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Status
- RECRUITING
- Phase
- PHASE3
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- Status
- RECRUITING
- Phase
- PHASE3
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Status
- RECRUITING
- Phase
- PHASE3
Effect of Small Interfering RNA Inclisiran on Carotid Plaques As Assessed by Carotid Ultrasound
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
The Prevent Coronary Artery Disease Trial
- Status
- RECRUITING
- Phase
- PHASE3
Continuity of Care Between Primary Care Cardiology and Specialty Services for Patients With Chronic Ischemic Heart Disease
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
- Status
- COMPLETED
- Phase
- PHASE4
Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction
- Status
- RECRUITING
- Phase
- PHASE4
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy
- Status
- RECRUITING
- Phase
- N/A
VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.
- Status
- COMPLETED
- Phase
- PHASE3
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
- Status
- RECRUITING
- Phase
- PHASE3
Impact of Optimal Pharmacotherapy on Lipid Profile and Qualitative Features of Atherosclerotic Plaques
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE)
- Status
- COMPLETED
- Phase
- PHASE3
Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome
- Status
- COMPLETED
- Phase
- PHASE3